Structural maintenance of chromosomes flexible hinge domain containing 1 (Smchd1) is an epigenetic repressor with described roles in X inactivation and genomic imprinting, but Smchd1 is also critically involved in the pathogenesis of facioscapulohumeral dystrophy. The underlying molecular mechanism by which Smchd1 functions in these instances remains unknown. Our genome-wide transcriptional and epigenetic analyses show that Smchd1 binds cis-regulatory elements, many of which coincide with CCCTC-binding factor (Ctcf) binding sites, for example, the clustered protocadherin (Pcdh) genes, where we show Smchd1 and Ctcf act in opposing ways. We provide biochemical and biophysical evidence that Smchd1-chromatin interactions are established through the homodimeric hinge domain of Smchd1 and, intriguingly, that the hinge domain also has the capacity to bind DNA and RNA. Our results suggest Smchd1 imparts epigenetic regulation via physical association with chromatin, which may antagonize Ctcf-facilitated chromatin interactions, resulting in coordinated transcriptional control.
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Smchd1 | epigenetic control | clustered protocadherins | Ctcf S tructural maintenance of chromosomes flexible hinge domain containing 1 (Smchd1) is an epigenetic repressor that has been shown to play an essential role in autosomal and X-linked gene repression, with critical consequences for normal biology and disease. Smchd1 was originally identified as an epigenetic modifier in an N-ethyl-N-nitrosourea (ENU) mutagenesis screen (1, 2) . The ENU-induced nonsense mutation, termed MommeD1, leads to dramatic reduction of Smchd1 transcripts and effectively produces a null allele (2) . Mice homozygous for this allele display female-specific embryonic lethality due to failure of X chromosome inactivation (2) . Although CpG island (CGI) hypomethylation was observed at promoters of a subset of X-linked genes in the absence of Smchd1 (2, 3), Smchd1-dependent gene silencing does not seem to be solely mediated by DNA methylation (4) . Indeed, a study of X inactivation in human cells has suggested that SMCHD1 may provide a link between different repressive histone modifications that facilitate heterochromatin formation (5) .
In addition to its role in X inactivation, Smchd1 regulates genomic imprinting of a subset of genes within the small nuclear ribonuclear protein N (Snrpn)-and Igf2r-imprinted clusters (4, 6, 7) , and Smchd1/SMCHD1 is involved in regulating the expression of the clustered protocadherin (Pcdh) genes (4, (6) (7) (8) . SMCHD1 has recently been implicated in the pathogenesis of facioscapulohumeral muscular dystrophy, where SMCHD1 is critical for epigenetic repression of the disease causal gene DUX4 (9, 10) . Furthermore, Smchd1 deficiency has been associated with accelerated tumorigenesis in mouse models (6) . These findings highlight that Smchd1/SMCHD1 participates in epigenetic regulation at multiple loci in many different cellular scenarios. However, the precise means by which Smchd1/SMCHD1 modulates gene expression in any of these cases is unknown.
Smchd1 is a noncanonical member of the structural maintenance of chromosomes (SMC) family, comprising an N-terminal ATPase domain and a C-terminal SMC hinge domain (2, 7, 11, 12) . SMC proteins form dedicated complexes that play fundamental roles in chromosome dynamics and are implicated in gene regulation, DNA repair, and disease (13) (14) (15) . The SMC hinge domain mediates dimerization of SMC proteins and confers differential DNA binding properties (14, (16) (17) (18) (19) (20) (21) . Unlike other SMC proteins, which form a composite ATPase domain from two subdomains that are brought into proximity upon SMC protein heterodimerization, Smchd1 possesses a predicted N-terminal ATPase domain encoded within a single Smchd1 protein. Interestingly, proteins containing an ATPase domain homologous to the ATPase domain of Significance Structural maintenance of chromosomes flexible hinge domain containing 1 (Smchd1) is a protein that plays an important role in maintaining gene silencing in many biological circumstances, including facioscapulohumeral muscular dystrophy; however, how it brings about gene silencing is unknown. Understanding the molecular mechanism by which Smchd1 contributes to stable transcriptional silencing is critical to appreciate how it functions in normal biology and when it is mutated in facioscapulohumeral muscular dystrophy. This study reveals, for the first time to our knowledge, where Smchd1 binds genome-wide, its hitherto unappreciated functional interaction with chromatin organizer CCCTC-binding factor in gene regulation, and which part of the protein is required for chromatin binding. These data lead to a new model of Smchd1 function, where it directly binds DNA to mediate 3D chromatin architecture.
Smchd1 have recently been implicated in heterochromatin compaction and gene silencing in Arabidopsis (12, 22) .
Previous results from immunofluorescence and ChIP experiments indicated that Smchd1/SMCHD1 is recruited to chromatin, including regions on the inactive X chromosome and at the DUX4 locus (2, 3, 5, 9) . However, the exact site to which Smchd1/ SMCHD1 is bound was not delineated, and detailed high-resolution analysis of Smchd1/SMCHD1 occupancy on a genome-wide scale was not available.
To address how Smchd1 affects gene expression at the molecular level, we use genome-wide approaches here and assess Smchd1's chromatin occupancy in conjunction with global gene expression analysis and epigenetic profiling. We find that many Smchd1 binding sites overlap with CCCTC-binding factor (Ctcf) occupancy at both promoters and distal cis-regulatory elements. In particular, we demonstrate that Smchd1 and Ctcf display opposing functional effects in regulating the clustered Pcdh genes. To investigate how Smchd1 binds to chromatin, we have used a suite of biochemical and biophysical assays, and report that the hinge domain of Smchd1 is capable of direct DNA and RNA binding in vitro. These results indicate that like Ctcf, Smchd1 directly interacts with chromatin but exerts distinct effects on transcription, adding a further layer of complexity in chromatin dynamics and epigenetic regulation.
Results
Transcriptome Analysis of Smchd1-Null Neural Stem Cells. To identify differentially expressed (DE) genes in neural stem cells (NSCs), we derived WT and Smchd1-null (Smchd1 MommeD1/MommeD1 ) NSCs from embryonic day 14.5 (E14.5) mouse brains. Only male cell lines were used in this study because Smchd1-null female embryos die around E10.5. We extracted RNA from NSCs (n = 3 per genotype) and performed next-generation sequencing, followed by bioinformatic analyses, to quantify the relative transcript levels. We identified 998 up-regulated and 199 down-regulated genes in Smchd1-null cells (Fig. 1A and Dataset S1). We performed a gene ontology (GO) analysis of these DE genes using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) (23, 24) , and found significant up-regulation of genes involved in cell adhesion and other neural-associated functions (Table S1 ). As expected, the transcript level of Smchd1 was dramatically reduced in Smchd1-null NSCs, owing to nonsense-mediated decay caused by the MommeD1 mutation. Consistent with previous studies, imprinted genes, including necdin (Ndn), makorin 3 (Mkrn3), and paternally expressed gene 12 (Peg12), were significantly up-regulated in mutant cells [ Fig. 1A and Dataset S1; P < 0.0001 by a rotation gene set test (ROAST) (25) of all imprinted genes]. We also found down-regulation of Grb10, for the first time to our knowledge, a gene that shows reciprocal imprinting in different areas of the brain (Dataset S1). Strikingly, almost all of the Pcdh genes within the alpha and beta clusters, a total of 31 genes, displayed elevated transcript levels ( Fig. 1A and Dataset S1; P < 0.005 by a ROAST (25) of all Pcdh genes), demonstrating a more widespread effect of Smchd1 on these clusters than previously reported in studies performed in whole brain or embryos (4, 7). These differences also likely explain the striking up-regulation of GO terms associated with cell adhesion.
Expression of Pcdh Genes Is Altered in Smchd1-Null NSCs. The observed up-regulation of Pcdh genes in Smchd1-null NSCs was verified by quantitative RT-PCR experiments. In agreement with the global analysis, the majority of Pcdh genes within the alpha and beta clusters were substantially up-regulated, although expression of genes within the gamma cluster was less perturbed in Smchd1 mutants (Fig. 1B) . These data suggest that Smchd1 regulates the expression of Pcdh genes, but in a nonuniform manner across the three Pcdh gene clusters.
Genome-Wide Occupancy of Smchd1 and Epigenetic Modification
Profiling. To uncover the mechanism by which Smchd1 modulates gene expression, we performed ChIP-sequencing (ChIP-seq) with an anti-Smchd1 antibody, using Smchd1-null NSCs as a negative control. Model-based analysis for ChIP-Seq 2 (MACS2) peak calling (26) identified 227 highly specific Smchd1 binding sites across the genome (Dataset S1). In parallel, we profiled key genome-wide epigenetic marks in WT and Smchd1-null NSCs (H3K4me3 and H3K27me3 ChIP-seq) and assessed CpG methylation via methyl binding domain (MBD)-seq. Fig. 1 . Gene expression analyses of WT and Smchd1-null NSCs. (A) Transcriptome-sequencing data represented by an log ratios versus mean averages (MA) plot showing the log-fold change (LogFC) of normalized expression levels between Smchd1-null and WT NSCs (n = 3 per genotype) against the average expression in log counts per million (LogCPM). Black dots are non-DE genes. Up-regulated and down-regulated genes (FC > 1.5, adjusted P < 0.01) are shown in pink and orange, respectively. Among the up-regulated genes, genes imprinted with Ndn, Mkrn3, and Peg12 are shown in blue. Pcdh alpha and beta genes are shown in red. (B) Quantitative RT-PCR (qRT-PCR) quantification of mRNA levels of Pcdh genes in alpha, beta, and gamma clusters from WT (blue) and Smchd1 null (red) NSCs (n = 3 per genotype). The qRT-PCR signal was normalized relative to the qRT-PCR signal of Rala and plotted relative to the corresponding WT sample. Data are displayed as mean + SEM and were analyzed by an unpaired two-tailed Student's t test with a Benjamini-Hochberg correction for multiple testing. *P < 0.05; **P < 0.01; ***P < 0.001.
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Chromatin Association of Smchd1 and Epigenetic Marks at the Pcdh
Gene Clusters. The strong altered expression profiles of the clustered Pcdh genes prompted us to examine whether Smchd1 was bound at the Pcdh clusters. Initially, we identified a prominent Smchd1 peak (chr18: 37218151-37218474, fold enrichment = 5.07; P < 5 × 10 , q < 0.1; *P < 5 × 10 and beta clusters ( Fig. 2A and Dataset S1). HS5-1 refers to the cisregulatory DNaseI hypersensitive site, which acts as a transcriptional enhancer of Pcdh alpha genes in the nervous system and is required for their repression in nonneuronal lineages (27, 28) . We noticed that subtle Smchd1 peaks might not be detected by our stringent genome-wide analysis because our Smchd1 ChIP-seq had considerable background. When we focused on the region spanning the clustered Pcdh genes and relaxed the cutoff set for MACS2 peak calling to P < 5 × 10
, four additional Smchd1 peaks were recovered, including three at promoter regions of the Pcdh genes and one at the HS5-1 site ( Fig. 2A and Dataset S1). Previous studies have demonstrated that the Ctcf/Cohesin complex (which contains a Smc1/Smc3 heterodimer) is localized at the HS5-1 site, as well as promoters of actively transcribed Pcdh alpha genes (27, 29, 30) . Smchd1 binding at the HS5-1 site and the Pcdh alpha promoter region was reminiscent of Ctcf/Cohesin occupancy compared with Ctcf peaks from the Encyclopedia of DNA Elements (ENCODE) E14.5 mouse brain dataset. In particular, two Ctcf/ Cohesin binding sites within the HS5-1 element, HS5-1a and HS5-1b (29, 30) , were both occupied by Smchd1 ( Fig. 2A and Dataset S1). However, we did not detect significant Smchd1 enrichment within the region spanning the beta and gamma clusters (Fig. S1 ).
We assessed whether Smchd1 deficiency altered the epigenetic modifications at the Pcdh clusters. We noticed an acquisition of the active mark H3K4me3 and a reduction of repressive CpG methylation at the promoters of individual Pcdh genes in Smchd1-null cells, predominantly for Pcdha1-a12 ( Fig. 2A and Fig. S1 ). This result was confirmed by read quantification comparing the Smchd1-null and WT NSC data. The calculated log 2 -fold change for H3K4me3 and CpG methylation at the region encompassing Pcdha1-a12 promoters was ∼2.23 and −0.74, respectively (Table S2 ). Similar analysis also revealed a discernible increase in H3K27me3 abundance in Smchd1-null cells at this region (Table  S2 ). Because H3K27me3 is usually associated with gene silencing, this finding was unexpected, potentially indicating some form of epigenetic compensation, albeit inadequate to maintain Pcdh repression. At the beta and gamma clusters, differential enrichment for H3K4me3 and CGI methylation was less apparent and H3K27me3 was not significantly changed in Smchd1-null NSCs ( Fig. S1 and Table S2 ).
These data demonstrate that Smchd1 is physically associated with regulatory elements that are implicated in Ctcf/Cohesinmediated transcription of Pcdh alpha genes. In Smchd1-null NSCs, altered epigenetic modifications, featuring increased H3K4me3 and reduced CpG methylation at promoters, are concomitant with the induced expression, mostly evident for the Pcdh alpha genes.
Chromatin Association of Smchd1 and Epigenetic Marks at the Snrpn-
Imprinted Gene Cluster. Smchd1-null cells show failed genomic imprinting at the Snrpn cluster, specifically for the distal half of the cluster encoding Ndn; melanoma antigen, family L, 2 (Magel2); Mkrn3; and Peg12, which are biallelically expressed in Smchd1-null cells (4, 7) . We again find up-regulation of Ndn, Mkrn3, and Peg12 here (Fig. 1A) , indicative of loss-of-imprinting and biallelic expression. Analysis of chromatin marks and CpG methylation in this region showed the expected enrichment of H3K4me3 at the promoters of the up-regulated genes (Ndn, Mkrn3, and Peg12) and loss of CpG methylation. No significant change in H3K27me3 enrichment was observed ( Fig. 2B and Table S2 ). We next examined Smchd1 localization in this region using MACS2 with higher (P < 5 × 10 −4
) and lower (P < 5 × 10 ) stringency settings, as we did for the Pcdh cluster. This analysis revealed seven Smchd1 peaks of enrichment: three within the cluster of genes and four more distally located. Interestingly, two Smchd1 peaks near Magel2 and Mkrn3, and two at the distal end of the region, overlap with Ctcf binding sites, suggesting that Smchd1 and Ctcf also have some relationship at the Snrpn locus. However, at three other Smchd1 peaks (at the Mkrn3 promoter and at two sites downstream of the genes), no such overlap exists, demonstrating that Smchd1 and Ctcf can bind unique sites (Fig. 2B) .
Chromatin Association of Smchd1 and Epigenetic Marks at Homeobox (Hox) Gene Clusters. Unexpectedly, our genome-wide analysis also identified Smchd1 binding sites at all four Hox gene clusters, some of which overlap with Ctcf peaks from the ENCODE E14.5 mouse brain dataset (Fig. S2) . Hox genes encode homeodomain transcription factors that are expressed in a spatially and temporally restricted manner, regulated partly via epigenetic mechanisms (31) (32) (33) . In embryonic forebrain, the region from which the NSCs were derived, Hox genes are repressed via polycomb group protein-mediated silencing (34). We did not detect expression of Hox genes in our forebrain-derived NSCs irrespective of the presence or absence of Smchd1. Furthermore, in both WT and Smchd1-null NSCs, all four Hox gene clusters were decorated with extensive H3K27me3 methylation (Fig. S2) . Thus, Smchd1 binding is dispensable for Hox gene silencing in NSCs.
Smchd1 Occupancy Coincides with Ctcf Binding Sites. To annotate the identified Smchd1 binding sites functionally across the genome, we defined the distribution of Smchd1 peaks with respect to gene transcription start sites (TSSs) using the Genomic Regions of Enrichment Analysis Tool (GREAT) algorithm (35) . We noticed that only 24% of Smchd1 peaks occur within 5 kb of annotated TSSs (Fig. 3A) . In contrast, there was a tendency for Smchd1 to be localized at regions distant from the TSSs (Fig.  3A) . These data suggest Smchd1 is not only involved in transcriptional repression at the TSSs but may also bind more distal regulatory elements, such as enhancers or insulators. To test this possibility, we examined Smchd1 occupancy in relation to cisregulatory elements in mouse E14.5 brain, defined by their transcription factor and chromatin mark profiles (36) . Strikingly, we observed that overlap between Ctcf and Smchd1 at the Pcdh and Snrpn clusters extended genome-wide: 138 of the 227 Smchd1 binding sites overlapped with Ctcf, of which 75 were devoid of promoter or enhancer elements ( Fig. 3B and Dataset S1). To rule out the possibility that those 75 sites contained inactive promoters (without H3K4me3 mark or Pol II binding), we applied the GREAT algorithm on those 75 sites and found that the majority of them were distant from TSSs (Fig. S3A) . Thus, our comparative analysis indicated that genome-wide Smchd1 occupancy coincided with Ctcf binding sites, featuring both promoters that are within close proximity of the TSSs and distal enhancers and insulators. This finding was further supported by our de novo motif analysis for Smchd1, which identified two statistically significant motifs corresponding to the Ctcf consensus sequence within 119 of the Smchd1 peaks ( Fig. 3C and Dataset S1). Additionally, a less common motif containing a sequence recognized by RE1 silencing transcription factor/neuron-restrictive silencer factor (Rest/Nrsf), a neuronal gene-specific transcription repressor (37, 38) , was identified in 38 Smchd1 peaks ( Fig. 3C and Dataset S1), whereas the other motifs identified do not represent known transcription factor binding sites. The top 10 Smchd1 motifs identified in this analysis are given in Fig. S3B .
Smchd1 and Ctcf Mediate Opposite Effects on the Expression of Pcdh
Genes. Given the potential co-occupancy of Smchd1 and Ctcf at cis-regulatory elements, we next investigated whether Smchd1 and Ctcf could coordinately regulate gene expression, focusing on the clustered Pcdh genes. We performed shRNA-mediated knockdown of Ctcf in NSCs with two independent hairpins, validated at both the mRNA and protein levels (Fig. S4) . We selected a set of 13 Pcdh genes to test, spread throughout the alpha, beta, and gamma clusters. Upon knockdown of Ctcf, there was noticeably reduced expression of a number of the Pcdh genes, compared with the negative control (Fig. 4A) , similar to the down-regulation of clustered Pcdh genes observed in Ctcf-deficient mouse brains (39) (Fig. 4A) . Together, these results suggest that Smchd1 and Ctcf evoke opposing effects on transcription of Pcdh genes, particularly those Pcdh genes of alpha and beta clusters. Whether this effect is coordinated through protein-protein interactions between Smchd1 and Ctcf is less clear, because we did not detect apparent interactions by immunoprecipitation under native conditions (Fig. S4) .
To elucidate the observed opposing effects of Smchd1 and Ctcf, we compared the chromatin localization of Ctcf in WT and Smchd1-null cells by performing Ctcf ChIP-seq, using NSCs with Ctcf knockdown as the negative control. Intriguingly, we identified additional Ctcf peaks at the promoters of Pcdha1-a12 genes in Smchd1-null cells (Fig. 4B and Dataset S1), concurrent with the gain of H3K4me3 and loss of CpG methylation as shown in Fig. 2A . (Fig. 5A ). In parallel, we generated a mutant Smchd1 hinge domain with a single amino acid substitution, R1867G (Fig. 5A) , mimicking the mutation present in a facioscapulohumeral muscular dystrophy type 2 family caused by a missense SMCHD1 mutation (40) . EMSA with ssDNA demonstrated a shift of 15-mer poly-dT and poly-dC by the WT Smchd1 hinge domain in a concentration-dependent manner, indicating binding, but there was no binding of poly-dA ssDNA (Fig. 5B) . The highly positive charge of the Smchd1 hinge domain meant it remained in the wells, or even ran toward the anode on these gels, similar to the pattern observed for the hinge domains of other SMC proteins (18) . Binding activity was dramatically diminished with the pathogenic mutation (Fig. 5B) .
To verify this finding, we adopted the thermal shift assay (TSA), which monitors the thermal denaturation of sample protein by the fluorescence intensity of the dye SYPRO orange upon its binding to denatured protein (41, 42) . In agreement with the EMSA results, we observed an elevated melting temperature of the WT Smchd1 hinge domain in the presence of ssDNA 30-mer poly-dT, indicating increased thermal stability induced by oligonucleotide binding. Furthermore, although the melting temperature of the R1867G mutant was indicative of a stable and correctly folded protein, such a shift was not observed for the R1867G mutant in the presence of oligonucleotides, reflecting its reduced capacity to bind DNA (Fig. 5C) .
To assess the Smchd1 hinge domain-oligonucleotide interactions quantitatively, we performed analytical ultracentrifugation (AUC). Using sedimentation velocity experiments and analyzing the data via the continuous size [c(s)] distribution or species analysis method (as implemented in the program SEDFIT), the concentration of bound 6-carboxyfluorescein (6-FAM) fluorescently labeled oligonucleotide in relation to the known concentration of the free The number of peaks corresponding to motif 4 (Rest/Nrsf consensus) from the de novo motif analysis is shown. Below the Venn diagram, we show the frequency with which other motifs are observed in those peaks without annotated regulatory motifs. (C) De novo motif analysis based on Smchd1 peak sequences identified motif 5 and motif 8, which are highly similar to the Ctcf consensus sequence, and motif 4, which is highly similar to the Rest/ Nrsf consensus.
oligonucleotide and protein was determined. From this experiment, the dissociation constant (K d ) was calculated (details are provided in SI Methods and Fig. S5 ). This method has the advantage of also reporting the oligomeric state of the free protein and the protein/ oligonucleotide complex. Within the concentration range of 1-40 μM, both the WT and R1867G mutant Smchd1 hinge domain proteins are dimeric, either free in solution or in complex with the oligonucleotides tested here. Consistent with the EMSA results, poly-dC displayed higher binding affinity than poly-dA. This result can be seen qualitatively when comparing the c(s) distributions of WT Smchd1 in the presence of either poly-dC or poly-dA (Fig. S5 C and D) . The poly-dC oligonucleotide distribution (Fig. S5D) clearly shows a peak at ∼3.5 Svedberg, consistent with the Smchd1/oligonucleotide complex, whereas this peak is absent in the distribution with poly-dA (Fig. S5C) . The K d for poly-dC was determined to be 2.5 ± 0.2 μM, and the K d for poly-dA was 66 ± 9 μM. The weak binding evident in the poly-A continuous size distribution and EMSA experiments also demonstrates that the 6-FAM label does not significantly contribute to protein binding. As expected based on EMSA and TSA data (above), the binding affinity was substantially decreased for the R1867G mutant hinge domain with both oligonucleotides (Fig. S5 C and D) .
We next tested oligonucleotides corresponding to the summit of the Smchd1 peak at the HS5-1b site. We found that the K d of 20-mer ssDNA containing a Ctcf motif in sense orientation exhibits comparable binding to 15-mer poly-dC and, again, that the R1867G mutant hinge domain had dramatically decreased binding affinity (Fig. 5 D and F) . In contrast, the binding affinity for the anti-senseorientated ssDNA was considerably compromised, with the K d being about 10-fold higher (Fig. 5F and Fig. S5F ). The dsDNA produced by annealing those two oligonucleotides was also bound by the WT hinge domain, albeit at an intermediate affinity (Fig. 5F  and Fig. S5H ). Previous studies demonstrated that CpG methylation at a single site could block Ctcf binding to 20-mer dsDNA probes (30) . Interestingly, similar CpG methylation did not abrogate binding of the Smchd1 hinge domain to the oligonucleotides (Fig. 5F and  Fig. S5 E, G, and I) . We next tested the effect of DNA methylation of two CpG sites next to a Ctcf motif within a Smchd1 binding site, between Magel2 and Mkrn3 in the Snrpn-imprinted cluster (Fig. 2B) Here, methylation resulted in enhanced affinity of the WT hinge domain for the oligonucleotide (Fig. 5 E and F) . Although the exact binding mode is unclear and subject to further investigation, together, these results demonstrate that the Smchd1 hinge domain binds to DNA in vitro, and therefore is a likely candidate for recruiting Smchd1 to its chromatin binding sites.
Because the Smchd1 hinge domain displayed the highest affinity for ssDNA, we used EMSA and AUC to analyze its RNA binding capacity. We found that the WT hinge domain shifted both 15-mer polyU and polyA RNA oligonucleotides in a concentrationdependent manner in EMSA (Fig. S6A) . AUC with the RNA oligonucleotides corresponding to the forward and reverse orientations of the Pcdha12 exonic Ctcf motif (29) demonstrated approximately equivalent binding as for the ssDNA oligonucleotides of the same motif (Fig. S6B) . In each case, binding was compromised for the R1867G mutant protein (Fig. S6) . These data raise the possibility that Smchd1, like Ctcf (43, 44) , may bind both DNA and RNA moieties to achieve its epigenetic function.
Discussion
Here, we present the first, to our knowledge, high-resolution ChIP-seq analysis of Smchd1 binding, which we performed in male murine NSCs. Previous studies have predominantly used immunofluorescence and ChIP/quantitative PCR to describe colocalization of Smchd1 with H3K27me3, H3K9me3, and DNA methylation (2-5, 7, 9) . Where ChIP-seq was reported (5), the data were analyzed in 150-kb nonoverlapping regions, possibly due to high background with their anti-SMCHD1 antibody, meaning that the data are of low resolution and would not identify sharp peaks such as we observed. Our high-resolution analysis of Smchd1 binding was enabled by using Smchd1-null samples as antibody controls; however, the background still may conceal more subtle features of Smchd1's pattern of binding. Our results are consistent with previous reports but offer deeper insight, which, in concert with our biochemical and biophysical assays, allows us to propose models for Smchd1 binding to chromatin.
We find that Smchd1-bound regions are not restricted to promoters and that many are distant from the TSSs. A significant proportion of Smchd1 binding sites overlap with Ctcf binding sites, with many being putative cis-regulatory elements, including promoters, enhancers, and insulators, indicating that Smchd1 serves a broad array of roles in regulating gene expression. Specifically, Smchd1 binding at the HS5-1 enhancer site and promoters of the clustered Pcdh genes (particularly Pcdha1-a12), along with specific Ctcf-bound promoters and enhancers in the Snrpn cluster, correlate with alterations to other epigenetic marks and expression of genes within these clusters. In the absence of Smchd1, we observed both acquisition of active histone mark H3K4me3 and loss of repressive CpG methylation at individual promoters of these genes, concomitant with their elevated gene expression. However, Smchd1 may not be the sole factor in determining transcriptional outcome because gene regulation often involves multiple redundant pathways. This fact is exemplified by the finding that despite loss of Smchd1 binding at the Hox gene clusters, the polycomb group protein-mediated H3K27me3 and gene repression were maintained in Smchd1-null male NSCs.
We used the Pcdh cluster as a sensitive model to examine the genetic interaction between Smchd1 and Ctcf. We demonstrated a potential functional interaction between Smchd1 and Ctcf by showing their opposing action in regulating Pcdh gene expression. Ctcf is known to be involved in regulating gene expression via mediating long-range chromatin interactions and partners with an array of transcription factors, chromatin proteins, and RNA molecules (43, (45) (46) (47) . It has been proposed that the Ctcf/Cohesin complex recruits selected Pcdh alpha promoters to the HS5-1 site, and thus creates an active transcriptional hub for maximal expression (30) (Fig. 6, Left) . In accordance with previous studies (30, 48) , we observed stable CpG methylation at Pcdha1-a12 promoters in WT NSCs that could potentially hinder Ctcf binding. On the other hand, additional Ctcf binding was observed at the hypomethylated promoters in Smchd1-null NSCs. Together with the discovery of Smchd1's localization at promoter regions and the HS5-1 site, these results have led us to hypothesize that Smchd1 may facilitate a repressive domain that potentially shields promoters of Pcdh genes from Ctcf binding (Fig. 6, Middle) . This model is further supported by our in vitro DNA binding analyses using EMSA together with complementary biophysical assays. However, it is unclear whether Smchd1 and Ctcf act in a competitive manner or whether they could simultaneously co-occupy the HS5-1 site in a cooperative way, where Smchd1 restrains the inactive promoters from the active transcriptional hub (Fig. 6 , Right). We propose that Ctcf selectively binds the unmethylated promoters, whereas Smchd1 engages with the methylated promoters to maintain their DNA methylation and repressed status; this model may also hold true at the Snrpn-imprinted cluster, given that Smchd1 binding is enhanced by DNA methylation for at least one site in this cluster. Our data support the idea that without Smchd1, Pcdh promoters are unleashed from a repressive chromatin environment, with pursuant engagement of Ctcf/Cohesin resulting in activation, at least for many of the Pcdh alpha genes.
In addition to overlap with Ctcf sites, we have identified a subset of Smchd1 binding sites that overlap with Rest/Nrsf occupancy. Rest/Nrsf is a transcription repressor that suppresses neural-specific gene expression in nonneuronal tissues (49) (50) (51) . It would be interesting to examine if Smchd1 cooperates with Rest/Nrsf in this process in the future. Beyond the clustered Pcdh genes, the functional significance of Smchd1 binding at other genomic loci, for example, at the Snrpn locus, is the subject of ongoing investigation.
To characterize how Smchd1 binds to chromatin, we used a variety of biochemical and biophysical analyses. These analyses have provided the basis for characterizing the exact DNA binding mode of the hinge domain of Smchd1. Our AUC data have revealed several previously unrecognized features of Smchd1: first, the Smchd1 hinge domain dimerizes, similar to the hinge domains from other SMC proteins (16, 17, 20) ; second, Smchd1 might directly associate with DNA via its hinge domain; third, Smchd1 has the potential to bind methylated DNA, consistent with its predicted function in maintaining DNA methylation (2, 4, 7); and, finally, Smchd1 has the potential to bind RNA. These data are consistent with our model of Smchd1 and Ctcf binding at the Pcdh alpha cluster, and they raise the intriguing possibility that like Ctcf (43), Smchd1 may also partner with RNA molecules for part of its epigenetic function. Given Smchd1's unique protein domain arrangement, with a C-terminal SMC hinge domain that directs chromatin interactions and an N-terminal putative ATPase domain, we are keen to investigate the possibility that Smchd1 exerts active manipulation at the chromatin level, and whether this function somehow requires RNA interaction.
In conclusion, our results reveal a potential involvement of Smchd1 in long-range chromatin interaction-mediated epigenetic regulation. We have established a functional link between Smchd1 and Ctcf in regulating expression of the Pcdh genes. The coincidence of Smchd1's genome-wide occupancy with a subset of Ctcf binding sites raises the intriguing possibility that Ctcf and its plethora of interacting factors may have some bearing on how Smchd1 regulates transcription. Interestingly, CTCF may also have the opposite effect of SMCHD1 in facioscapulohumeral muscular dystrophy (52) . Therefore, further characterization of Smchd1's DNA binding sites and in vivo RNA binding partners in other cellular contexts will provide deeper insights into the molecular mechanism of Smchd1-mediated gene regulation and the underlying implications for development and disease. MommeD1/+ females were dissected out in Leibovitz's L-15 Medium (Gibco) using NSCs as described previously, and as detailed in SI Methods (53).
Transcriptome Sequencing and Analysis. RNA and DNA were extracted from WT and Smchd1 MommeD1/MommeD1 male NSCs using an AllPrep DNA/RNA Mini Kit (Qiagen) according to the manufacturer's instructions and were quantified using a NanoDrop 1000 Spectrophotometer (Thermo Scientific). RNA integrity was assessed with an Agilent Bioanalyzer 2100 (Agilent Technologies) according to the manufacturer's instructions. Sequencing libraries were prepared with a TruSeq Stranded Total RNA Sample Preparation Kit (Illumina) according to the manufacturer's instructions. Sequencing and analysis were as described in SI Methods.
MBD-Seq. Genomic DNA was extracted from WT and Smchd1
MommeD1/MommeD1 male NSCs. After purification and fragmentation, methylated DNA was isolated using the MethylMiner Methylated DNA Enrichment Kit (Life Technologies) according to the manufacturer's instructions. The DNA was eluted from MBD-coupled beads in two salt concentration cuts: first, a 600 mM NaCl cut to remove poorly methylated DNA, followed by a 2 M NaCl cut to elute highly methylated DNA; the latter was used for the preparation of libraries for nextgeneration sequencing Details are provided in SI Methods.
ChIP-Seq and Analysis. ChIP was performed with the fast ChIP protocol (54) with modifications as detailed in SI Methods. Antibodies used were as follows: Smchd1 (31865; Abcam), H3K4me3 (07-473; Millipore), H3K27me3 (07-449; Millipore), and Ctcf (07-729; Millipore). Library preparation and sequencing were performed using standard protocols (SI Methods). Analysis details are provided in SI Methods.
Cloning, Expression, and Purification of Recombinant Protein. cDNA encoding amino acids 1683-1899 of Smchd1 was PCR-amplified from a full-length cDNA clone and cloned into a pPROEX HTb vector (Life Technologies) for expressing 6-His-tagged recombinant protein. The R1867G mutation was introduced by oligonucleotide-directed PCR mutagenesis. Details of the expression and purification procedure are provided in SI Methods.
EMSA. The EMSA was performed with 6-FAM fluorescence-labeled and HPLCpurified oligonucleotides (Integrated DNA Technologies) dissolved in 10 mM Tris·HCl (pH 8.5). The dsDNA was annealed by mixing equal volumes of 100 μM ssDNA (strands 1 and 2), incubated at 95°C for 5 min, and then gradually cooled down to room temperature. The EMSA was performed using the method described by Griese et al. (18) and is detailed in SI Methods.
TSA. The TSA was performed using the method described by Murphy et al. (42) , with modifications as detailed in SI Methods.
AUC. AUC experiments were conducted using a Beckman Coulter model XL-I instrument at 20°C. Protein and 6-FAM fluorescently labeled oligonucleotides were mixed in 100 mM NaCl and 20 mM Hepes (pH 7.5), loaded into double-sector quartz cells, and mounted in a Beckman Coulter eight-hole An-50 Ti rotor. Details of the experiments and analyses are included in SI Methods, and additional details are shown in Figs. S5 and S6.
